Xtant Medical Holdings, Inc. financial data

Symbol
XTNT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
664 Cruiser Lane, Belgrade, Montana
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Bacterin International Holdings, Inc. (to 8/3/2015), K KITZ INC (to 5/21/2010)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 260 % -16.4%
Quick Ratio 144 % +16%
Debt-to-equity 86.2 % +5.34%
Return On Equity -3.6 % +86.2%
Return On Assets -1.93 % +86.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 130 M shares +19.6%
Common Stock, Shares, Outstanding 130 M shares +19.6%
Entity Public Float 25.8 M USD +269%
Weighted Average Number of Shares Outstanding, Basic 130 M shares +19.6%
Weighted Average Number of Shares Outstanding, Diluted 130 M shares +19.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 101 M USD +60.8%
Research and Development Expense 1.69 M USD +92.8%
Selling and Marketing Expense 43.8 M USD +80%
General and Administrative Expense 28.8 M USD +75.6%
Operating Income (Loss) -12.1 M USD -85.4%
Nonoperating Income (Expense) 8.75 M USD -76.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.3 M USD +60.2%
Income Tax Expense (Benefit) -1.64 M USD -2883%
Net Income (Loss) Attributable to Parent -1.66 M USD +80.1%
Earnings Per Share, Basic 0 USD/shares -50%
Earnings Per Share, Diluted 0 USD/shares -50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.55 M USD -12.2%
Accounts Receivable, after Allowance for Credit Loss, Current 21.5 M USD +80.5%
Inventory, Net 38.7 M USD +109%
Assets, Current 66.5 M USD +81.9%
Property, Plant and Equipment, Net 8.87 M USD +29.9%
Operating Lease, Right-of-Use Asset 1.44 M USD +13.2%
Intangible Assets, Net (Excluding Goodwill) 9.65 M USD -10.7%
Goodwill 7.3 M USD -4.41%
Other Assets, Noncurrent 132 K USD -28.6%
Assets 93.9 M USD +48.4%
Accounts Payable, Current 7.38 M USD +116%
Accrued Liabilities, Current 9.88 M USD +76.5%
Liabilities, Current 28.4 M USD +64.6%
Deferred Income Tax Liabilities, Net 21 K USD
Operating Lease, Liability, Noncurrent 644 K USD -24%
Other Liabilities, Noncurrent 240 K USD
Liabilities 46.3 M USD +51.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -133 K USD
Retained Earnings (Accumulated Deficit) -247 M USD -0.68%
Stockholders' Equity Attributable to Parent 47.7 M USD +45.8%
Liabilities and Equity 93.9 M USD +48.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.76 M USD -156%
Net Cash Provided by (Used in) Financing Activities 5.18 M USD +13.4%
Net Cash Provided by (Used in) Investing Activities -674 K USD +96.1%
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 130 M shares +19.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.3 M USD +91.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.62 M USD -14.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 740 K USD +45.4%
Deferred Tax Assets, Valuation Allowance 25.8 M USD +24%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 26.6 M USD +24.9%
Operating Lease, Liability 1.59 M USD +11.1%
Depreciation 2.1 M USD +75%
Payments to Acquire Property, Plant, and Equipment 773 K USD +69.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.56 M USD -120%
Lessee, Operating Lease, Liability, to be Paid 1.72 M USD +9.85%
Property, Plant and Equipment, Gross 29.4 M USD +17.3%
Operating Lease, Liability, Current 853 K USD +80.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 680 K USD +21.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 918 K USD +71.9%
Deferred Income Tax Expense (Benefit) -1.9 M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 128 K USD -3.76%
Lessee, Operating Lease, Liability, to be Paid, Year Three 119 K USD -74.7%
Deferred Tax Assets, Operating Loss Carryforwards 18.6 M USD +35.7%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -1.42 M USD
Current Income Tax Expense (Benefit) 204 K USD +196%
Preferred Stock, Shares Authorized 10 M shares 0%
Additional Paid in Capital 295 M USD +6.02%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 93 K USD +34.8%
Amortization of Intangible Assets 400 K USD +300%
Depreciation, Depletion and Amortization 1.01 M USD +113%
Deferred State and Local Income Tax Expense (Benefit) -479 K USD
Interest Expense 3.2 M USD +67.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%